Carmela
Gómez Rodríguez
Hospital Nacional de Parapléjicos
Toledo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Nacional de Parapléjicos (1)
2024
-
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Spinal Cord, Vol. 62, Núm. 8, pp. 454-467